{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-092604","form_type":"8-K","ticker":"CTXR","cik":"0001506251","company_name":"Citius Pharmaceuticals, Inc.","filed_at":"2026-08-21T20:15:14+00:00","discovered_at":"2026-08-21T20:16:00.446689+00:00","generated_at":"2026-08-21T20:16:17.886307+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Citius Pharma gets Nasdaq bid-price compliance extension to Feb 8, 2027","bullets":["Nasdaq granted extension to Feb 8, 2027 to regain compliance with $1.00 bid price rule.","Must close at or above $1.00 for 10 consecutive business days before deadline.","Failure to comply by Feb 8, 2027 triggers delisting notice; company may appeal.","Stock remains listed on Nasdaq Capital Market under CTXR; no immediate effect.","Company evaluating options; no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-092604","json":"https://secwatch.observer/filing/0001213900-26-092604.json","markdown":"https://secwatch.observer/filing/0001213900-26-092604.md","text":"https://secwatch.observer/filing/0001213900-26-092604.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506251/000121390026092604/0001213900-26-092604-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506251/000121390026092604/ea0302856-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-21T20:16:17.886307+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}